1,151
Views
9
CrossRef citations to date
0
Altmetric
Research Article

DNA/chitosan nanocomplex as a novel drug carrier for doxorubicin

, , , , , , , & show all
Pages 135-144 | Received 15 Sep 2008, Accepted 16 Oct 2008, Published online: 01 Apr 2009

References

  • Moghimi SM, Hunter AC, Murray JC. (2001). Long-circulating and target-specific nanoparticles: therory to practice. Pharmacol Rev, 53, 283–318.
  • Maitani Y, Aso Y, Yamada A, Yoshioka S. (2008). Effect of sugars on storage stability of lyophilized liposome/DNA complexes with high transfection efficiency. Int J Pharm, 356, 69–75.
  • Liu BR, Yang M, Li RT, Ding YT, Qian XP, Yu LX, Jiang XQ. (2008). The antitumor effect of novel docetaxel-loaded thermosensitive micelles. Eur J Pharm Biopharm, 69, 527–34.
  • Lacoeuille F, Hindre F, Moa F, Roux J, Passirani C, Couturier O, Cales P, Le Jeune JJ, Lamprecht A, Benoit JP. (2007). In vivo evaluation of lipid nanocapsules as a promising colloidal carrier for paclitaxel. Int J Pharm, 344, 143–9.
  • Li S, Huang L. (1997). In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Gene Ther, 4, 891–900.
  • Okuda T, Kawakami S, Akimoto N, Niidome T, Yamashita F, Hashida M. (2006). PEGylated lysine dendrimers for tumor-selective targeting after intravenous injection in tumor-bearing mice. J Contr Rel, 116, 330–6.
  • Yadav AK, Mishra P, Mishra AK, Mishra P, Jain S, Agrawal GP. (2007). Development and characterization of hyaluronic acid–anchored PLGA nanoparticulate carriers of doxorubicin. Nanomed Nanotech Biol Med, 3, 246–57.
  • Nimesh S, Kumar R, Chandra R. (2006). Novel polyallylamine– dextran sulfate–DNA nanoplexes: highly efficient non-viral vector for gene delivery. Int J Pharm, 320, 143–9.
  • Gref R, Minamitake Y, Peracchia MT, Trubetskoy V, Torchilin V, Langer R. (1994). Biodegradable long-circulating polymeric nanospheres. Science, 263, 1600–3.
  • Santander-Ortega MJ, Csaba N, Alonso MJ, Ortega-Vinuesa JL, Bastos-González D. (2007). Stability and physicochemical characteristics of PLGA, PLGA:poloxamer and PLGA:poloxamine blend nanoparticles: a comparative study. Colloid Surf A Physicochem Eng Asp, 296, 132–40.
  • Howard KA, Dash PR, Read ML, Ward K, Tomkins LM, Nazarova O, Ulbrich K, Seymour LW. (2000). Influence of hydrophilicity of cationic polymers on the biophysical properties of polyelectrolyte complexes formed by self-assembly with DNA. Biochim Biophys Acta, 1475, 245–55.
  • Hirano S, Seino H, Akiyama Y, Nonaka I. (1989). Biocompatibility of chitosan by oral and intravenous administration. Polym Eng Sci, 59, 897–901.
  • Lee KY, Kwon IC, Kim YH, Jo WH, Jeong SY. (1998). Preparation of chitosan self-aggregates as a gene delivery system. J Contr Rel, 51, 213–20.
  • Artursson P., Lindmark T., Davis S.S., Illum L. (1994). Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). Pharm Res, 11:1358–61.
  • Sato T, Ishii T, Okahata Y. (2001). In vitro gene delivery mediated by chitosan. Effect of pH, serum, and molecular mass of chitosan on the transfection efficiency. Biomaterials, 22, 2075–80.
  • Corsi K, Chellat F, Yahia LH, Fernandes JC. (2003). Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan-DNA nanoparticles. Biomaterials, 24, 1255–64.
  • Satoh T, Kakimoto S, Kano H, Nakatani M, Shinkai S, Nagasaki T. (2007). In vitro gene delivery to HepG2 cells using galactosylated 6-amino-6-deoxychitosan as a DNA carrier. Carbohyd Res, 342, 1427–33.
  • Thanou M, Florea BI, Langemeÿer MWE, Verhoef JC, Junginger HE. (2000). N-Trimethylated chitosan chloride (TMC) improves the intestinal permeation of the peptide drug buserelin in vitro (Caco-s cells) and in vivo (Rats). Pharm Res, 17, 27–31.
  • Janes KA, Fresneau MP, Marazuela A, Fabra A, Alonso MJ. (2001). Chitosan nanoparticles as delivery systems for doxorubicin. J Contr Rel, 73, 255–67.
  • Banerjee T, Mitra S, Singh AK, Sharma RK, Maitra A. (2002). Preparation, characterization and biodistribution of ultrafine chitosan nanoparticles. Int J Pharm, 243, 93–105.
  • Qaqish RB, Amiji MM. (1999). Synthesis of a fluorescent chitosan derivative and its application for the study of chitosan-mucin interactions. Carbohyd Polym, 38, 99–107.
  • Gao SY, Chen JN, Xu XR, Ding Z, Yang YH, Hua ZC, Zhang JF. (2003). Galactosylated low molecular weight chitosan as DNA carrier for hepatocyte-targeting. Int J Pharm, 255, 57–68.
  • Gummow BD, Roberts GAF. (1985). Studies on chitosan-induced metachromasy, 1. Metachromatic behavior of sodium 2’-hydroxy-1, 1’-azonaphthalene-4-sulfonate in the presence of chitosan. Makromol Chem, 186, 1239–44.
  • Kataoka K, Matsumoto T, Yokoyama M, Okano T, Sakurai Y. (2000). Doxorubicin-loaded poly(ethylene glycol)-poly(β- benzyl-L-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance. J Contr Rel, 64, 143–53.
  • Yamaguchi R, Arai Y, Itoh T. (1981). Preparation of partially N-succinylated chitosans and their cross-linked gels. Carbohydr Res, 88, 172–5.
  • Song Y, Onishi H, Machida Y, Nagai T. (1996). Drug release and antitumor characteristics of N-succinyl-chitosan-mitomycin C as an implant. J Contr Rel, 42, 93–100.
  • Schwartz HS. (1973). A fluorometric assay for daunomycin and adriamycin in animal tissues. Biochem Med, 7, 396–404.
  • Onishi H, Machida Y. (1999). Biodegradation and distribution of water-soluble chitosan in mice. Biomaterials, 20, 175–82.
  • Wall DA, Wilson G, Hubbard AL. (1980). The galactose-specific recognition system of mammalian liver: the route of ligand internalization in rat hepatocytes. Cell, 21, 79–93.
  • Nishikawa M, Ohtsubo Y, Ohno J, Fujita T, Koyama Y, Yamashita F, Hashida M, Sezaki H. (1992). Pharmacokinetics of receptor-mediated hepatic uptake of glycosylated albumin in mice. Int J Pharm, 85, 75–85.
  • Kaneo Y, Tanaka T, Nakano T, Yamaguchi Y. (2001). Evidence for receptor-mediated hepatic uptake of pullulan in rats. J Contr Rel, 70, 365–73.
  • Stolnik S, Daudali B, Arien A, Whetstone J, Heald CR, Garnett MC, Davis SS, Illum L. (2001). The effect of surface coverage and conformation of poly(ethylene oxide) (PEO) chains of poloxamer 407 on the biological fate of model colloidal drug carriers. Biochim Biophys Acta, 1514, 261–79.
  • Avgoustakis K, Beletsi A, Panagi Z, Klepetsanis P, Livaniou E, Evangelatos G, Ithakissios DS. (2003). Effect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA-mPEG nanoparticles. Int J Pharm, 259, 115–27.
  • Romero EL, Morilla MJ, Regts J, Koning GA, Scherphof GL. (1999). On the mechanism of hepatic transendothelial passage of larger liposomes. FEBS Lett, 448, 193–6.
  • Andre T, Daniele DC, Christian DD. (1972). Chemotherapy through lysosomes with a DNA-daunorubicin complex. Nature New Biol, 239, 110–2.
  • Chytil P, Etrych T, Koňák č, šírová M, Mrkvan T, říhová B, Ulbrich K. (2006). Properties of HPMA copolymer–doxorubicin conjugates with pH-controlled activation: Effect of polymer chain modification. J Contr Rel, 115, 26–36.
  • Rodrigues PCA, Beyer U, Schumacher P, Roth T, Fiebig HH, Unger C, Messori L, Orioli P, Paper DH, Mülhaupt R, Kratz F. (1999). Acid-sensitive polyethylene glycol conjugates of doxorubicin: preparation, in vitro efficacy and intracellular distribution. Bioorgan Med Chem, 7, 2517–24.
  • Kato Y, Onishi H, Machida Y. (2000). Evaluation of N-succinyl-chitosan as a systemic long-circulating polymer. Biomaterials, 21, 1579–85.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.